
Profitability, historical returns, and peer comparisons.
According to INNOCAN PHARMA Corp’s latest financial reports and current stock price. The company's current ROE is -19.37%. This represents a change of 128.17% compared to the average of -8.49% of the last 4 quarters.
The mean historical ROE of INNOCAN PHARMA Corp over the last ten years is -139.93%. The current -19.37% ROE has changed -86.15% with respect to the historical average. Over the past ten years (40 quarters), INNPF's ROE was at its highest in in the December 2020 quarter at 174.44%. The ROE was at its lowest in in the September 2019 quarter at -5243.48%.
Average
-139.93%
Median
-85.96%
Minimum
-938.58%
Maximum
420.88%
Discovering the peaks and valleys of INNOCAN PHARMA Corp ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 88.33%
Maximum Annual ROE = 420.88%
Minimum Annual Increase = -262.09%
Minimum Annual ROE = -938.58%
| Year | ROE | Change |
|---|---|---|
| 2025 | -20.08% | -43.44% |
| 2024 | -35.49% | -69.01% |
| 2023 | -114.55% | 88.33% |
| 2022 | -60.82% | -45.25% |
| 2021 | -111.10% | -126.40% |
| 2020 | 420.88% | -262.09% |
| 2019 | -259.66% | -72.33% |
The current ROE of INNOCAN PHARMA Corp (INNPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-56.71%
5-year avg
-68.41%
10-year avg
-139.93%
INNOCAN PHARMA Corp’s ROE is less than BioNxt Solutions Inc. (117.02%), less than Rapid Dose Therapeutics Corp. (42.51%), less than Pharmadrug Inc. (37.95%), greater than RAMM Pharma Corp. (-194.41%), less than Revive Therapeutics Ltd. (26.78%), less than PreveCeutical Medical Inc. (10.15%), less than Lifeist Wellness Inc. (0.38%), greater than Glow Lifetech Corp. (-10.61%),
| Company | ROE | Market cap |
|---|---|---|
| 117.02% | $35.38M | |
| 42.51% | $15.01M | |
| 37.95% | $671.07K | |
| -194.41% | $1.19M | |
| 26.78% | $8.71M | |
| 10.15% | $12.76M | |
| 0.38% | $1.33M | |
| -10.61% | $7.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like INNOCAN PHARMA Corp using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like INNOCAN PHARMA Corp or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is INNOCAN PHARMA Corp's ROE?
How is the ROE calculated for INNOCAN PHARMA Corp (INNPF)?
What is the highest ROE for INNOCAN PHARMA Corp (INNPF)?
What is the 3-year average ROE for INNOCAN PHARMA Corp (INNPF)?
What is the 5-year average ROE for INNOCAN PHARMA Corp (INNPF)?
How does the current ROE for INNOCAN PHARMA Corp (INNPF) compare to its historical average?